At the end of the latest market close, Atossa Therapeutics Inc. (ATOS) was valued at $0.96. In that particular session, Stock kicked-off at the price of $0.98 while reaching the peak value of $1.10 and lowest value recorded on the day was $0.932. The stock current value is $1.10.
Recently in News on January 8, 2021, COVID-19 Origin and Spread Linked to PLA Hospital and Wuhan Metro System Line 2 by Physician-Scientist Dr. Steven Quay. Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NASDAQ: ATOS ), recently shared his latest research and findings regarding the origins of COVID-19 and the manner in which it spread so quickly. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Atossa Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.2100 on 01/05/21, with the lowest value was $0.8750 for the same time period, recorded on 01/06/21.
Atossa Therapeutics Inc. (ATOS) full year performance was -29.94%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Atossa Therapeutics Inc. shares are logging -78.35% during the 52-week period from high price, and 45.70% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $5.08.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 28708382 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Atossa Therapeutics Inc. (ATOS) recorded performance in the market was 15.79%, having the revenues showcasing -52.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 47.72M, as it employees total of 2 workers.
The Analysts eye on Atossa Therapeutics Inc. (ATOS)
During the last month, 0 analysts gave the Atossa Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.8018, with a change in the price was noted -2.6100. In a similar fashion, Atossa Therapeutics Inc. posted a movement of -70.35% for the period of last 100 days, recording 3,136,402 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATOS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Atossa Therapeutics Inc. (ATOS)
Raw Stochastic average of Atossa Therapeutics Inc. in the period of last 50 days is set at 27.36%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.50%. In the last 20 days, the company’s Stochastic %K was 48.17% and its Stochastic %D was recorded 35.18%.
Considering, the past performance of Atossa Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 15.79%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -67.26%, alongside a downfall of -29.94% for the period of the last 12 months. The shares increased approximately by 15.79% in the 7-day charts and went down by 26.18% in the period of the last 30 days. Common stock shares were lifted by -52.79% during last recorded quarter.